KKR Mortgage REIT Slashes Dividend, Accelerates Troubled Loan Resolution
KKR Real Estate Finance Trust reported a first-quarter loss Thursday, and CEO Matt Salem declared that "2026 is a transition year for KREF" as it adjusts to shifting demand in the life sciences and office sectors.
KREF’s $5.1B portfolio of real estate debt generated a $4M loss for shareholders in the first quarter, compared to $14M in distributable earnings for the fourth quarter and $17M during the same period a year earlier.
The REIT slashed its quarterly dividend from 25 cents to 10 cents, and Salem said the fund's managers were taking aggressive action to reposition the portfolio and rotate into newer, higher-quality assets.
“Our action plan is designed to reposition the portfolio to optimize medium- and long-term performance. However, as we execute, we may choose to incur book value declines as we seek liquidity on legacy assets to create a higher-quality portfolio,” Salem said on the managed REIT’s earnings call Thursday.
KREF shares fell by roughly 25% after posting its results but have recovered some of their value since then. They were down roughly 8.5% this week in trading early Friday.
While the REIT cut its dividend, it also approved a plan to buy back up to $75M in stock, which Salem said would provide better returns to shareholders. KREF repurchased roughly $800K in shares in January, and the REIT repurchased 4.6 million shares across 2025 for a combined $43M.
“The dividend decision reflects a disciplined approach to capital allocation. At this stage, we see more attractive opportunities, including repurchasing our stock and funding new originations,” he said.
Management is aiming to cut its exposure to “legacy office” assets from 21% to less than 10% by the end of the year, and KREF is actively marketing its largest watchlisted office loan for sale. It's planning to clear the current watchlist by year-end through sales, loan modification and accelerated resolution.
KREF modified 30% of its life sciences portfolio in the first quarter and increased its reserves in anticipation of a potential modification of a loan for a lab project in Boston’s Seaport District.
KREF included a $73.5M charge to its provision for credit losses in its first-quarter results, up from $43.7M in the fourth quarter.
The REIT’s portfolio of senior loans is diversified across asset classes, with 41% in multifamily assets at the end of the first quarter, 22% in industrial space, 18% in office buildings and 14% in the life sciences sector. The vast majority of its portfolio backs U.S. assets, with its largest concentration of loans in California, Massachusetts, Texas and Florida.
KREF collected $415M in loan repayments in the first quarter, originated a $184M loan and funded a $188M note. It invested $42M in CMBS securities and diversified its credit sources to total $7.2B, with $2.6B in undrawn capacity.
Its $951M office loan portfolio includes a $199M loan on a property in Minneapolis with a credit risk rating of five, indicating a high likelihood of default, and loans for properties in Chicago and Philadelphia totaling $219M that are flagged as facing some level of uncertainty.
Its life sciences portfolio has two loans covering properties in Boston and totaling $479M with a credit risk rating of five. KREF expects to take control of one Boston life sciences property backed by a $166M loan in the second quarter, KREF Chief Operating Officer Patrick Mattson said on the earnings call.
“This is expected to result in a realized loss of approximately $37M, though we are adequately reserved as of the first quarter,” he said.
